Nocil Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 20, 2026

Key Highlights

The Latest Trading Price of NOCIL Ltd is ₹ 141.65 as of 20 Mar 12:41 . The P/E Ratio of NOCIL Ltd changed from 32.8 on March 2021 to 28.4 on March 2025 . This represents a CAGR of -2.84% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of NOCIL Ltd changed from ₹ 2902 crore on March 2021 to ₹ 2921 crore on March 2025 . This represents a CAGR of 0.13% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of NOCIL Ltd for the Dec '25 is ₹ 322.04 crore as compare to the Sep '25 revenue of ₹ 330.74 crore. This represent the decline of -2.63% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of NOCIL Ltd for the Dec '25 is ₹ 27.63 crore as compare to the Sep '25 ebitda of ₹ 32.5 crore. This represent the decline of -14.98% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of NOCIL Ltd changed from ₹ 27.06 crore to ₹ 9.25 crore over 7 quarters. This represents a CAGR of -45.85% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of NOCIL Ltd changed from 38.44 % on March 2021 to 31.05 % on March 2025 . This represents a CAGR of -4.18% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About NOCIL Ltd

NOCIL Limited was incorporated on May 11, 1961 as 'National Organic Chemical Industries Limited'.
During the period 2007-08, name of the Company was changed from National Organic Chemical Industries Limited to NOCIL Limited on September 14, 2007. NOCIL is India's largest manufacturer and supplier of rubber chemicals.
The Company is a part of Arvind Mafatlal Group of Industries, a well-known Business House in India with diversified business interests.
It has manufacturing plants at Navi Mumbai (Maharashtra) and at Dahej (Gujarat).
It offer a range of rubber chemicals, such as PILFLex, which is a rubber anti-degradant, PILnox, which is a rubber antioxidant, PILcure, which is a rubber accelerator, and PILGarD, which is a rubber pre-vulcanization inhibitor.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of NOCIL Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, NOCIL Ltd or Saroja Pharma Industries India Ltd?

Market cap of NOCIL Ltd is 2,338 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of NOCIL Ltd and Saroja Pharma Industries India Ltd?

The stock performance of NOCIL Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for NOCIL Ltd and Saroja Pharma Industries India Ltd?

As of March 20, 2026, the NOCIL Ltd stock price is INR ₹140.0. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹29.6.

How do dividend payouts of NOCIL Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of NOCIL Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.